StockWatch
·
Pharmaceuticals
Board Meeting28 Oct 2026, 03:42 pm

Akums Drugs Board Meeting on Nov 2, 2026 for Q2/H1 FY27 Results

AI Summary

Akums Drugs and Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 2, 2026. The primary agenda item is the consideration and approval of the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Following the declaration of these results, the trading window for the company's securities, which is currently closed, will reopen 48 hours thereafter. The company will also update this disclosure on its website.

Key Highlights

  • Board meeting scheduled for November 2, 2026.
  • To approve un-audited financial results for Q2 and H1 FY27.
  • Trading window to reopen 48 hours after results announcement.
  • Financial results will be standalone and consolidated.